BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36635438)

  • 1. Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design.
    Xu J; Zhang H; Zhang H; Bian J; Wang F
    Sci Rep; 2023 Jan; 13(1):613. PubMed ID: 36635438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Validity of a
    Li Q; He Z; Guo Y; Zhang H; George TJ; Hogan W; Charness N; Bian J
    AMIA Annu Symp Proc; 2019; 2019():1101-1110. PubMed ID: 32308907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer's Disease Trials.
    Li Q; Guo Y; He Z; Zhang H; George TJ; Bian J
    AMIA Annu Symp Proc; 2020; 2020():717-726. PubMed ID: 33936446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsupervised machine learning for the discovery of latent disease clusters and patient subgroups using electronic health records.
    Wang Y; Zhao Y; Therneau TM; Atkinson EJ; Tafti AP; Zhang N; Amin S; Limper AH; Khosla S; Liu H
    J Biomed Inform; 2020 Feb; 102():103364. PubMed ID: 31891765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On using electronic health records to improve optimal treatment rules in randomized trials.
    Wu P; Zeng D; Fu H; Wang Y
    Biometrics; 2020 Dec; 76(4):1075-1086. PubMed ID: 32365232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.
    Kim JH; Ta CN; Liu C; Sung C; Butler AM; Stewart LA; Ena L; Rogers JR; Lee J; Ostropolets A; Ryan PB; Liu H; Lee SM; Elkind MSV; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):14-22. PubMed ID: 33260201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.
    Lombardo G; Couvert C; Kose M; Begum A; Spiertz C; Worrell C; Hasselbaink D; Didden EM; Sforzini L; Todorovic M; Lewi M; Brown M; Vaterkowski M; Gullet N; Amasi-Hartoonian N; Griffon N; Pais R; Rodriguez Navarro S; Kremer A; Maes C; Tan EH; Moinat M; Ferrer JG; Pariante CM; Kalra D; Ammour N; Kalko S
    J Biomed Inform; 2023 Dec; 148():104553. PubMed ID: 38000766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department.
    Ni Y; Kennebeck S; Dexheimer JW; McAneney CM; Tang H; Lingren T; Li Q; Zhai H; Solti I
    J Am Med Inform Assoc; 2015 Jan; 22(1):166-78. PubMed ID: 25030032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic data source identification for clinical trial eligibility criteria resolution.
    Shivade C; Hebert C; Regan K; Fosler-Lussier E; Lai AM
    AMIA Annu Symp Proc; 2016; 2016():1149-1158. PubMed ID: 28269912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Eligibility Criteria on Patients' Survival and Serious Adverse Events in Colorectal Cancer Drug Trials.
    Wang C; Chen A; He X; Balian P; George TJ; Wang F; Bian J; Guo Y
    medRxiv; 2024 Apr; ():. PubMed ID: 38633798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for discovering and inferring appropriate eligibility criteria in clinical trial protocols without labeled data.
    Restificar A; Korkontzelos I; Ananiadou S
    BMC Med Inform Decis Mak; 2013; 13 Suppl 1(Suppl 1):S6. PubMed ID: 23566239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data.
    Köpcke F; Lubgan D; Fietkau R; Scholler A; Nau C; Stürzl M; Croner R; Prokosch HU; Toddenroth D
    BMC Med Inform Decis Mak; 2013 Dec; 13():134. PubMed ID: 24321610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a Clinical Trial-Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer.
    Coquet J; Bievre N; Billaut V; Seneviratne M; Magnani CJ; Bozkurt S; Brooks JD; Hernandez-Boussard T
    JAMA Netw Open; 2021 Jan; 4(1):e2031730. PubMed ID: 33481032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting time-evolving phenotypic topics via tensor factorization on electronic health records: Cardiovascular disease case study.
    Zhao J; Zhang Y; Schlueter DJ; Wu P; Eric Kerchberger V; Trent Rosenbloom S; Wells QS; Feng Q; Denny JC; Wei WQ
    J Biomed Inform; 2019 Oct; 98():103270. PubMed ID: 31445983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of Eligibility Criteria on Trial Participants' Age in Alzheimer's Disease Clinical Trials.
    Chen A; Li Q; He X; Jaffee MS; Hogan WR; Wang F; Guo Y; Bian J
    AMIA Annu Symp Proc; 2022; 2022():368-376. PubMed ID: 37128470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.
    Ateya MB; Delaney BC; Speedie SM
    BMC Med Inform Decis Mak; 2016 Jan; 16():1. PubMed ID: 26754574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.